The TRIPOD checklist for decision tree development is provided in Appendix Table 5.   Supplementary Table 1 Pre-randomization characteristics of included participants from the ACCORD Trial (2001-2009, N = 10,251) . Decimals of binary characteristics refer to proportions of each sample with the listed characteristic (e.g., 0.38 = 38% of the standard glycemic therapy arm was female).
Characteristic
Standard glycemic therapy arm (n=5123) P-value (logrank test) Leaf 1 (leftmost in Fig.  2 Appen dix Funding 22 D;V Give the source of funding and the role of the funders for the present study. 15 *Items relevant only to the development of a prediction model are denoted by D, items relating solely to a validation of a prediction model are denoted by V, and items relating to both are denoted D;V. We recommend using the TRIPOD Checklist in conjunction with the TRIPOD Explanation and Elaboration document. Figure 1 . Survival curves for the composite microvascular outcome of renal failure, end-stage renal disease (dialysis), serum creatinine>3.3 mg/dL, photocoagulation or vitrectomy, or Michigan Neuropathy Screening Instrument score >2.0, among subsets identified by each subgroup in the decision tree (see Figure 2 for subgroups). P values are from the stratified log-rank test adjusted for censorship of Kaplan-Meier cardiovascular mortality rates among the intensive versus standard glycemic therapy arm. Legend: CVD = cardiovascular disease; HGI = hemoglobin glycosylation index; BMI = body mass index.
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